Yuanbao
YB
11.78
-0.24
-1.96%
Yuanbao
US · YB
#3681 by market cap
Listed 2025
11.78
-0.24
-1.96%
Live - 5344 symbols - heartbeat 222s ago
· 2026-10-08 09:46
Pre-market
12.19
+1.50%
After-hours
12.25
+2.00%
- Market cap
- 542.59M
- P/E (TTM)i
- 2.41
- P/Bi
- 0.96
- EPSi
- 4.09
- Div yieldi
- 10.72%
- 52W posi
- 6%
Reader sentiment
Are you bullish or bearish on YB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.97, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +33.14% YoY
Margins
- Gross margin
- 91.06%
- Operating margin
- 30.56%
- Net margin
- 45.92%
Key ratios & quality
- PEG ratioi
- 0.01
- Altman Z-Scorei
- 2.97
PEG uses trailing P/E against the 3-year net income growth rate (311.59%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 385.44M | 850.25M | 2.05B | 3.28B | 4.37B |
| Gross profit | 311.67M | 748.74M | 1.83B | 2.95B | 3.98B |
| Selling & admin expenses | 581.90M | 639.21M | 1.47B | 1.79B | 2.22B |
| Research & development | 89.61M | 78.43M | 128.53M | 231.04M | 365.11M |
| Operating profit | -403.61M | -16.17M | 175.36M | 858.61M | 1.34B |
| Pretax profit | -399.86M | -2.34M | 205.48M | 891.41M | 1.41B |
| Tax | 0 | 12.00K | 291.00K | 25.57M | 101.17M |
| Net profit | -441.51M | 18.75M | 203.12M | 865.85M | 1.31B |
| Basic EPS | -27 | -10 | -7 | 10 | 56 |
| Diluted EPS | -27.02 | -9.66 | -7.39 | 9.67 | 27.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 970.06M | 1.07B | 1.16B | 1.18B | 1.32B | 1.39B |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 559.79M | 649.57M | 662.74M | 351.68M | 724.84M | 744.05M |
| Research & development | 76.10M | 81.72M | 95.56M | 111.73M | 106.34M | 99.45M |
| Operating profit | 289.41M | 297.73M | 354.54M | 394.90M | 437.23M | 450.89M |
| Pretax profit | 301.82M | 315.81M | 378.27M | 412.81M | 457.00M | 473.08M |
| Tax | 6.72M | 11.12M | 7.91M | 75.43M | 69.36M | 59.93M |
| Net profit | 295.10M | 304.69M | 370.36M | 337.38M | 387.65M | 413.15M |
| Basic EPS | 7 | 27 | 8 | 8 | 9 | 9 |
| Diluted EPS | 6.55 | 6.48 | 7.68 | 6.96 | 8.04 | 8.58 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 716.95M | 990.58M | 1.41B | 2.67B | 4.46B |
| Cash & ST investments | 577.34M | 641.38M | 1.12B | 2.32B | 3.96B |
| Inventory | -- | -- | -- | -- | -- |
| Total assets | 790.33M | 1.08B | 1.52B | 2.78B | 4.66B |
| Total current liabilities | 267.75M | 472.48M | 634.15M | 940.81M | 1.14B |
| Short-term debt | 2.57M | 10.04M | 12.44M | 13.45M | 7.08M |
| Long-term debt | -- | -- | -- | -- | -- |
| Total liabilities | 284,180,000.00 | 502,468,000.00 | 667,079,000.00 | 992,555,000.00 | 1,309,273,000.00 |
| Total equity | 506.15M | 574.55M | 853.57M | 1.79B | 3.35B |
| Retained earnings | -1.52B | -1.95B | -2.29B | -1.93B | -72.85M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.14B | 3.80B | 4.10B | 4.46B | 5.24B | 5.80B |
| Cash & ST investments | 2.75B | 3.40B | 3.68B | 3.96B | 4.67B | 5.14B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.25B | 3.91B | 4.26B | 4.66B | 5.46B | 5.98B |
| Total current liabilities | 1.10B | 1.24B | 1.20B | 1.14B | 1.50B | 1.99B |
| Short-term debt | 13.55M | 13.61M | 10.27M | 7.08M | 3.85M | 1.62M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,149,288,000.00 | 1,296,867,000.00 | 1,267,299,000.00 | 1,309,273,000.00 | 1,710,187,000.00 | 2,201,178,000.00 |
| Total equity | 2.10B | 2.61B | 3.00B | 3.35B | 3.75B | 3.78B |
| Retained earnings | -1.62B | -631.54M | -261.18M | -72.85M | 314.80M | 338.23M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -244.99M | 87.72M | 441.97M | 1.21B | 1.50B |
| Depreciation & amortization | 8.43M | 9.52M | 16.14M | 14.95M | 17.68M |
| Free cash flow | -248.14M | 85.28M | 437.33M | 1.20B | 1.48B |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | 204.88M |
| Ending cash balance | 558.93M | 452.56M | 873.91M | 1.92B | 883.98M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | 234.55 |
| ROA %i | -154.11 | -46.63 | -25.63 | 20.27 | 54.02 |
| ROIC %i | -- | -- | -- | -- | 228.54 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -104.71 | -1.90 | 8.57 | 26.14 | 30.56 |
| FCF / sales %i | -- | 10.03 | 21.38 | 36.66 | 33.75 |
| Current ratioi | 2.68 | 2.10 | 2.22 | 2.84 | 3.91 |
| Quick ratioi | 2.37 | 1.83 | 2.17 | 2.74 | 3.87 |
| Debt / assetsi | 0.43 | 2.25 | 2.04 | 0.69 | 0.17 |
| LT debt / equityi | -- | -- | -- | -- | 0.03 |
| Interest coveragei | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 104.25 | 72.62 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | 311.59 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | 158.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | 460.69 | 327.38 | 234.55 | 169.79 | 47.21 |
| ROA %i | 21.07 | 51.41 | 55.80 | 54.02 | 47.76 | 30.51 |
| ROIC %i | -- | 429.50 | 314.10 | 228.54 | 166.84 | 46.57 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 28.55 | 29.80 | 30.12 | 30.56 | 31.46 | 32.48 |
| FCF / sales %i | -- | -- | -- | 33.75 | -- | -- |
| Current ratioi | 2.86 | 3.07 | 3.40 | 3.91 | 3.48 | 2.91 |
| Quick ratioi | 2.81 | 3.04 | 3.37 | 3.87 | 3.45 | 2.88 |
| Debt / assetsi | 0.49 | 0.39 | 0.27 | 0.17 | 0.08 | 0.03 |
| LT debt / equityi | -- | 0.06 | 0.04 | 0.03 | 0.01 | 0.00 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- System services is the largest reported line at 68.74% of revenue, across 2 reported segments.
- Insurance distribution services follows at 31.26%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
System services68.74%
Insurance distribution services31.26%
Quote time 2026-10-08 09:46:59 · For reference only, not investment advice and not tailored to your situation.